Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The hydrophobic, membrane-binding domain of purified human erythrocyte
acetylcholinesterase
was labeled with the photoactivated reagent 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. The radiolabel was incorporated when the enzyme was prepared in detergent-free aggregates, in detergent micelles, or in phospholipid liposomes, but the highest percentage of labeling occurred in the detergent-free aggregates. Papain digestion of the enzyme released the hydrophobic domain, and polyacrylamide gel electrophoresis in sodium dodecyl sulfate or gel exclusion chromatography demonstrated that the label was localized exclusively in the cleaved hydrophobic domain fragment. This fragment was purified in a three-step procedure. Digestion was conducted with papain attached to Sepharose CL-4B, and the supernatant was adsorbed to acridinium affinity resin to remove the hydrophilic enzyme fragment. The nonretained fragment associated with
Triton X-100
micelles was then chromatographed on Sepharose CL-6B, and finally detergent was removed by chromatography on Sephadex LH-60 in an ethanol-formic acid solvent. The fragment exhibited an apparent molecular weight of 3100 on the Sephadex LH-60 column when compared with peptide standards. However, amino acid analysis of the purified fragment revealed only 1 mol each of histidine and glycine per mole of fragment in contrast to the 25-30 mole of amino acids expected on the basis of the molecular weight estimate. This result suggests a novel non-amino acid structure for the hydrophobic domain of human erythrocyte
acetylcholinesterase
.
...
PMID:Selective radiolabeling and isolation of the hydrophobic membrane-binding domain of human erythrocyte acetylcholinesterase. 352 70
The efficiency of several nonionic detergents and a homologous series of zwitterionic detergents for the extraction of
acetylcholinesterase
(
EC 3.1.1.7
) from bovine erythrocyte membranes was examined. Of the nonionic detergents examined, the polyoxyethylene-based Tweens were the least effective solubilizing agents. Within this series, increasing the length of the saturated fatty acid chain progressively decreased the efficiency of enzyme recovery, while unsaturation in the side chain reversed this trend. In the Lubrol detergents, where the chain length of the alcohol group is variable, an increase in the length of the polyoxyethylene glycol group decreased the recovery of
acetylcholinesterase
in the solubilized state, without affecting the efficiency of extraction of total erythrocyte protein. As with the other nonionic detergents examined,
Triton X-100
and octyl beta-D-glucoside were maximally effective in solubilizing
acetylcholinesterase
activity at concentrations greater than their respective critical micelle concentrations. In the sulfobetaine (N-alkyldimethylaminopropane sulphonate) zwitterionic detergent series, the longer alkyl chain zwittergents Z 316 and Z 314 were more efficient than the shorter chain length members of the series (Z 310 and Z 312). In contrast to the higher chain length compounds, short chain analogs were maximally effective at or below their critical micelle concentrations. After purification by ion-exchange chromatography and affinity chromatography, the enzyme extracted with the various detergents gave sedimentation coefficients between 6.8S and 7.6S, consistent with a dimeric structure. Acetylcholinesterase could also be efficiently released by 0.2 mM EDTA or 0.5 M NaCl from bovine erythrocyte membranes previously depleted of 70-80% of the membrane lipids by butanol. Nonlinear Arrhenius plots of enzyme activity were found whether
acetylcholinesterase
was solubilized with Tween 20, Lubrol PX, or
Triton X-100
. The present work confirms that bovine erythrocyte
acetylcholinesterase
requires detergents to solubilize it from membranes and that its activity depends on the structure of the amphiphiles used to solubilize the enzyme.
...
PMID:The efficiency of various detergents for extraction and stabilization of acetylcholinesterase from bovine erythrocytes. 356 71
Activity of
acetylcholinesterase
(
EC 3.1.1.7
) and pseudocholinesterase (EC 3.1.1.8) was measured in extracts from chick corneas, in a developmental series from days 7-20 of incubation and at three ages after hatching. Enzyme activity was measured by the biphasic single-vial radiometric assay of Johnson and Russell using [3H-acetyl]choline as substrate. Pseudocholinesterase was inhibited with tetraisopropylpyrophosphoramide (iso-OMPA). True
acetylcholinesterase
activity was verified by control assays run in the presence of both iso-OMPA and the true
acetylcholinesterase
inhibitor, 1:5-bis(4-allyldimethyl-ammonium phenyl)-pentane-3-one diiodide (BW284c51). With both inhibitors present, no
cholinesterase
activity was detected. Corneal
acetylcholinesterase
had an average Km of 1.1 +/- 0.3 X 10(-3) M at day 7, 14, and 20 of development and retained 90% activity even after 3 hr at 26 degrees C. At least 90% of the total
cholinesterase
activity was solubilized by
Triton X-100
and sonication treatment. Activity decreased with increasing concentrations of NaCl present in the assay. A 60-fold transient increase in
acetylcholinesterase
specific activity occurs during the period from days 7-20 of embryonic development. This increase begins on the first day measured (day 7), progresses steadily and rapidly during the subsequent week, reaches a peak at day 15, and then decreases rapidly before hatching to a level maintained into adulthood. A similar pattern of transient appearance of highly sialylated gangliosides seen previously on days 14-17 leads to an hypothesis of a structural linkage between
acetylcholinesterase
and the plasma membrane lipids of corneal epithelial cells.
...
PMID:Acetylcholinesterase activity in the cornea of the developing chick embryo. 357 Jun 95
The embryonic development of total specific activities as well as of molecular forms of
acetylcholinesterase
(AChE,
EC 3.1.1.7
) and of butyrylcholinesterase (BChE, EC 3.1.1.8) have been studied in the chick brain. A comparison of the development in different brain parts shows that cholinesterases first develop in diencephalon, then in tectum and telencephalon;
cholinesterase
development in retina is delayed by about 2-3 days; and the development in rhombencephalon [not studied until embryonic day 6 (E6)] and cerebellum is last. Both enzymes show complex and independent developmental patterns. During the early period (E3-E7) first BChE expresses high specific activities that decline rapidly, but in contrast AChE increases more or less constantly with a short temporal delay. Thereafter the developmental courses approach a late phase (E14-E20), during which AChE reaches very high specific activities and BChE follows at much lower but about parallel levels. By extraction of tissues from brain and retina in high salt plus 1%
Triton X-100
, we find that both cholinesterases are present in two major molecular forms, AChE sedimenting at 5.9S and 11.6S (corresponding to G2 and G4 globular forms) and BChE at 2.9S and 10.3S (G1 and G4, globular). During development there is a continuous increase of G4 over G2 AChE, the G4 form reaching 80% in brain but only 30% in retina. The proportion of G1 BChE in brain remains almost constant at 55%, but in retina there is a drastic shift from 65% G1 before E5 to 70% G4 form at E7.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Quantitative development and molecular forms of acetyl- and butyrylcholinesterase during morphogenesis and synaptogenesis of chick brain and retina. 358 28
Acetylcholinesterase was solubilized from rabbit white muscle by means of dilute buffer and
Triton X-100
(0.5%). About 50% of total activity was brought into solution with buffer, the rest being solubilized by extracting the tissue with buffer and
Triton X-100
. The enzyme activity recovered in the supernatants was 170% of that found in the homogenate in the absence of
Triton X-100
indicating that, to some extent, the enzyme could be found in an occluded form in muscle. At suboptimum substrate concentration the Triton-solubilized
acetylcholinesterase
displayed a negative cooperativity, this phenomenon being greatly modified in the presence of NaCl. As the salt concentration increased (0-400 mM) the enzyme activity decreased, the Km values being linearly-dependent on the NaCl concentration in the assay medium. We propose a kinetic pattern to explain both the negative cooperativity produced by the substrate and the effect of NaCl on the kinetic behaviour on this enzyme. Our data are consistent with the hypothesis of binding of substrate to both the catalytic anionic site and a peripheral anionic site, the salt showing the capacity to compete with the substrate for these two binding sites.
...
PMID:Influence of NaCl on the kinetic behaviour of mammalian muscle acetylcholinesterase. 359 83
Attempts were made to solubilize
acetylcholinesterase
(
AChE
) from microsomal membranes isolated from rabbit white muscle. The preparative procedure included a step in which the microsomes were incubated in a solution containing high salt concentration (0.6 M KCl). About 15% of the total enzyme activity could be solubilized with dilute buffer. Addition of EDTA (1 mM), EGTA (1 mM) or NaCl (0.5 and 1 M) to the extraction buffer did not improve the solubilization yield. Several non-ionic detergents and biliary salts were then used to bring the enzyme into solution.
Triton X-100
, C12E9 (dodecylnonaethylenglycol monoether) and biliary salt, above their critical micellar concentration, proved to be very effective as solubilizing agents. The occurrence of multiple molecular forms in detergent-soluble
AChE
was investigated by means of molecular sieving, centrifugation analysis, and slab gel electrophoresis. Experiments on gel filtration showed that, during the process, half of the enzyme was transformed into aggregates, the rest of the activity appearing as peaks with Stokes radii ranging from 3.7 to 7.9 nm. Both ionic strength and detergent nature modify the number and relative proportion of these peaks. Centrifugation analysis of Triton-saline-soluble
AChE
yielded molecular forms of 4.8S, 10-11S, and 13.5S, whereas deoxycholate extracts revealed species of 4.8S, 10S, and 15S, providing that gradients were prepared with 0.5 M NaCl. In the absence of salt, forms of 6.5-7.5S, 10S, and 15S were measured. The lightest species was always the predominant form. Slab gel electrophoresis showed several bands (68,000-445,000). The 4.8S component only yielded bands of 65,000-70,000.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Solubilization and partial characterization of acetylcholinesterase from the sarcotubular system of skeletal muscle. 361 10
The membrane-bound
acetylcholinesterase
(AchE) from human peripheral blood lymphocyte gives only one symmetrical peak on sucrose density gradient centrifugation in the presence of
Triton X-100
detergent, with the calculated sedimentation coefficient of 6.5 S. However, this dimeric form of AchE was converted to a monomeric 3.8 S form when treated with 2-mercaptoethanol and iodoacetic acid. The results are consistent with studies which have shown by sodium dodecyl sulfate gel electrophoresis that the enzyme is built up of two identical monomers inter-linked by disulfide bond(s). Under reducing conditions, revealed a single species of 70,000 molecular weight, whereas under non-reducing conditions, another species of 140,000 molecular weight of the AchE was found. Polyacrylamide gel electrophoresis indicated a single band with AchE activity in the presence of
Triton X-100
. In contrast, in the absence of the same detergent multiple band pattern could be observed. These results suggest that membrane-bound AchE enzyme is present in homogenous dimeric form on human lymphocyte membrane.
...
PMID:Molecular form of human lymphocyte membrane-bound acetylcholinesterase. 365 87
The benzomorphan opiate, (-)N-allynormetazocine [(-)ANMC, (-)SKF10047], has been shown previously to bind two distinct sites on acetylcholine receptor (AChR)-rich membranes from Torpedo electroplaque. The low affinity site seems to correspond to the site for noncompetitive blockers on the AChR. The high affinity site, which can be photoaffinity labeled using UV irradiation, was distinct from this site. We show here, using a variety of techniques, that the high affinity binding site for (-)ANMC is on the
acetylcholinesterase
(
AChE
) associated with these membranes. The
Triton X-100
-solubilized peptide photolabeled with (-)[3H]ANMC co-migrates with
acetylcholinesterase
activity on velocity sucrose gradient centrifugation and fast protein liquid chromatography. In addition, the labeled peptide cannot be precipitated with monoclonal or polyclonal antibodies raised against the nicotinic AChR but can be precipitated with anti-
AChE
antibodies. Localization of the binding site on
AChE
was confirmed by photolabeling of and reversible binding to the 11 S
AChE
purified from Torpedo californica. The binding and photolabeling had characteristics and affinity similar to those for the high affinity binding site in Torpedo electroplaque membranes. Competition studies with specific
AChE
inhibitors suggest that the binding site may be the catalytic site of the enzyme, which exists on the 66-kDa globular protein. The effect of (-) and (+)ANMC on
AChE
activity was also investigated. ANMC inhibited
AChE
activity at micromolar concentrations in a stereoselective fashion, with the (-)isomer exhibiting a 2-fold higher affinity than the (+) isomer. The inhibition was consistent with a competitive blockade of
AChE
activity.
...
PMID:Interaction of a benzomorphan opiate with acetylcholinesterase and the nicotinic acetylcholine receptor. 367 Feb 80
To establish if the predominant form of
acetylcholinesterase
in muscle microsomes (4.8S) corresponded to the monomeric or dimeric form of the enzyme we studied the sensitivity to heating of
Triton X-100
solubilized extract and that of 4.8S, 10-11S and 13.5S species of the enzyme. Inactivation of soluble
acetylcholinesterase
began at 45-47 degrees C and was almost complete at 60 degrees C. Sedimentation analysis revealed that the partial loss of activity was due to inactivation of the 4.8S form, although by heating the 13.5S was converted into the 10S enzyme. Inactivation of the 4.8S form began at 45 degrees C, whereas the larger forms required higher temperature. The 4.8S component follows a time course of inactivation which could be fitted by a double exponential equation (when heated at 52 degrees C, almost 83% of the activity showed a short half-life). The 10-11S species was also inactivated following a two step process while the 13.5S enzyme was fairly stable at 52 degrees C. The results show that the lightest component behaves as a monomeric form of
acetylcholinesterase
.
...
PMID:Thermal stability of molecular forms of acetylcholinesterase from muscle microsomes. 372 65
Developmental regulation, from the fetal period to 11 months of age, and the influence of denervation on the appearance and disappearance of the molecular forms of
acetylcholinesterase
(AchE) and butyrylcholinesterase (BuchE) in rat skeletal muscle were examined. The enzyme forms were extracted from anterior tibialis in 0.01 M sodium phosphate buffer, pH 7.0, containing 1 N NaCl, 0.01 M EGTA, 1%
Triton X-100
, and a cocktail of antiproteases, and analyzed by velocity sedimentation on 5-20% linear sucrose gradients. Three principal forms, denoted by sedimentation coefficients of 4, 10.8, and 16 S, were observed in muscle from all age groups. The amounts of each of the molecular forms of AchE and BuchE in skeletal muscle exhibited distinct and reciprocal patterns of appearance and disappearance during pre- and postnatal development. In tissue derived from animals less than 2 weeks of age, BuchE represented the predominant component of activity in the 4 S form, was present equally with AchE in the 10.8 S form, and was subordinate to AchE in the 16 S form. Between 1 and 2 weeks of age a progressive increase in AchE activities coincident with a reduction in BuchE activities resulted in inversion in the amounts of the two enzymes present in adult muscle. Denervation of muscle caused a dramatic reduction in the presence of AchE molecular forms with no discernable influence on the presence of BuchE molecular forms. These results indicate that biosynthesis of BuchE is strictly regulated in a reciprocal manner with that of AchE, and that BuchE metabolism is independent of the state of muscle innervation. Increased synthesis of AchE and either reduced synthesis or increased degradation of BuchE can account for the reciprocal regulation of these enzymes. These characteristics of mammalian muscle contrast sharply with characteristics deduced for avian tissue (Silman et al. (1979) Nature (London) 280, 160-162). The innervation-independent metabolism of BuchE and the diverse modes of its regulation in different tissue from different species signify that BuchE function may be unrelated to cholinergic neurotransmission.
...
PMID:Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscle. 381 86
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>